JKE-1674

CAS No. 2421119-60-8

JKE-1674 ( —— )

Catalog No. M28123 CAS No. 2421119-60-8

JKE-1674 is an inhibitor of glutathione peroxidase 4 (GPX4). JKE-1674 is an active metabolite of the GPX4 inhibitor ML-210.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 102 Get Quote
10MG 165 Get Quote
25MG 335 Get Quote
50MG 537 Get Quote
100MG 860 Get Quote
200MG 1152 Get Quote
500MG 1701 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    JKE-1674
  • Note
    Research use only, not for human use.
  • Brief Description
    JKE-1674 is an inhibitor of glutathione peroxidase 4 (GPX4). JKE-1674 is an active metabolite of the GPX4 inhibitor ML-210.
  • Description
    JKE-1674 is an inhibitor of glutathione peroxidase 4 (GPX4). JKE-1674 is an active metabolite of the GPX4 inhibitor ML-210.(In Vitro):JKE-1674 reduces the viability of LOX-IMVI cancer cells with an EC50 of 0.03 μM and in a panel of additional cancer cell lines. JKE-1674 is completely rescued by ferroptosis inhibitors.(In Vivo):JKE-1674 (50?mg/kg; p.o.) could be detected in the serum of mice dosed orally with the compound.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    IL-5
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2421119-60-8
  • Formula Weight
    451.3
  • Molecular Formula
    C20H20Cl2N4O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(C(C[N+]([O-])=O)=NO)N1CCN(C(C2=CC=C(Cl)C=C2)C3=CC=C(Cl)C=C3)CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ian D Pavord, From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseases. Allergy. 2022 Mar;77(3):778-797.
molnova catalog
related products
  • BMS-536924

    BMS-536924 is an ATP-competitive IGF-1R/IR inhibitor with IC50 of 100 nM/73 nM, modest activity for Mek, Fak, and Lck with very little activity for Akt1, MAPK1/2.

  • AKOS B018304

    AKOS B018304 is an arylalkylidene derivative with polar substitution at para-position.

  • Tamgermanetin

    Tamgermanetin demonstrates potential cytotoxic effect against three different tumor cell lines, namely liver (Huh-7), breast (MCF-7) and prostate (PC-3).